Raf-l protein kinase has been identified as an integral component of the Ra
s/Raf/MEK/ERK signalling pathway in mammals. Activation of Raf-l is achieve
d by Ras,GTP binding and other events at the plasma membrane including tyro
sine phosphorylation at residues 340/341, We have used gene targeting to ge
nerate a 'knockout' of the raf-l gene in mice as well as a rafFF mutant ver
sion of endogenous Raf-l with Y340FY341F mutations. Raf-1(-/-) mice die in
embryogenesis and show vascular defects in the yolk sac and placenta as wel
l as increased apoptosis of embryonic tissues. Cell proliferation is not af
fected. Raf-l from cells derived from raf-1(FF/FF) mice has no detectable a
ctivity towards MEK in vitro, and yet raf-1(FF/FF) mice survive to adulthoo
d, are fertile and have an apparently normal phenotype, In cells derived fr
om both the raf-1(-/-) and raf-1(FF/FF) mice, ERK activation is normal. The
se results strongly argue that MEK kinase activity of Raf-l is not essentia
l for normal mouse development and that Raf-l plays a key role in preventin
g apoptosis.